Bahamas vs Gambia: Previously treated cases tested for RR-/MDR-TB
Bahamas
100.0%
in 2020
Gambia
100.0%
in 2024
Bahamas rank
1st
Gambia rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bahamas
- Gambia
How they compare
Bahamas currently reports 100.0% against 100.0% in Gambia, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2007 it was Gambia ahead.
Bahamas ranks 1st and Gambia ranks 1st of 180 countries.
Across the 3 decades both report, Bahamas averaged higher in 2 and Gambia in 1.
Head to head by decade
| Decade | Bahamas | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 61.0% | 13.0% | Bahamas |
| 2010s | 52.8% | 62.5% | 9.7% | Gambia |
| 2020s | 100.0% | 47.0% | 53.0% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bahamas or Gambia?
- Bahamas, at 100.0% against 100.0% in Gambia as of 2020.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bahamas and Gambia?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Gambia?
- 10 years are reported by both, from 2007 to 2020.
- How do Bahamas and Gambia rank globally for previously treated cases tested for rr-/mdr-tb?
- Bahamas ranks 1st and Gambia ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.